Results 181 to 190 of about 19,810 (255)

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Muoio B, Iacovitti CM, Bosetti DG, Sansovini M, Cuzzocrea M, Paone G, Treglia G.   +6 more
europepmc   +1 more source

AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy. [PDF]

Eur J Nucl Med Mol Imaging
Laudicella R, Faggiano A, Pirro V, Durmo R, Salsi P, Modica R, Urso L, Grana CM, Sances D, Rinzivillo M, Albertelli M, Spada F, Partelli S, Ferraù F, Fazio N, Tafuto S, Maccauro M, Bartolomei M, Panzuto F, De Rimini ML, Lastoria S, Filice A.   +21 more
europepmc   +1 more source

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Singh A, Sanduleanu S, Kulkarni HR, Langbein T, Lambin P, Baum RP.   +5 more
europepmc   +1 more source

Considerations for Establishing Peptide Receptor Radionuclide Therapy: A Nationally Coordinated, Collaborative, and Equitable Service for New Zealand. [PDF]

World J Nucl Med
Steyn R, Henderson A, Wells K, Mead T, Rennie Y, Hull A, Meredith L, Sullivan M, Simmers S, Davidson J, Hauraki T, Damianovich D, Boyle V, Lawrence B.   +13 more
europepmc   +1 more source

Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Mathew A, Kersting D, Fendler WP, Braegelmann J, Fuhrer D, Lahner H.   +5 more
europepmc   +1 more source

Fibrosis markers as prognostic markers of decline in kidney function in patients with neuroendocrine neoplasms undergoing peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Stemann Lau T, Bossen L, Rasmussen DGK, Genovese F, Karsdal M, Arveschoug AK, Grønbæk H, Dam G.   +7 more
europepmc   +1 more source

Multicycle Dosimetric Behavior and Dose-Effect Relationships in [¹⁷⁷Lu]Lu-DOTATATE Peptide Receptor Radionuclide Therapy. [PDF]

J Nucl Med
Kayal G, Roseland ME, Wang C, Fitzpatrick K, Mirando D, Suresh K, Wong KK, Dewaraja YK.   +7 more
europepmc   +1 more source

Peptide receptor radionuclide therapy for patients with somatostatin receptor expressing tumours. German Guideline (S1).

, 2015
Thorsten D. Poeppel, Christian Boy, A. Bockisch, J. Kotzerke, Inga Buchmann, Samer Ezziddin, Klemens Scheidhauer, Bernd J. Krause, Dominique Schmidt, Holger Amthauer, Frank Rösch, James Nagarajah, Dagmar Führer, Harald Lahner, Gabriele Pöpperl, Dieter Hörsch, Martin A. Walter, R. P. Baum   +17 more
openalex   +1 more source

Peptide receptor radionuclide therapy

, 2023
openaire   +1 more source